MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/mcp.R500004-MCP200 on January 31, 2005.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
R500004-MCP200v1
4/4/523    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, R.
Right arrow Articles by Aebersold, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, R.
Right arrow Articles by Aebersold, R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 4:523-533, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.

Review

Proteomic Profiling of Pancreatic Cancer for Biomarker Discovery*

Ru Chen{ddagger}, Sheng Pan§, Teresa A. Brentnall{ddagger},¶ and Ruedi Aebersold§,||

From the {ddagger} GI Division/Department of Medicine, University of Washington, Seattle, WA 98195; § Institute for Systems Biology, Seattle, WA 98103; and || Institute for Molecular Systems Biology, ETH Zurich and Faculty of Nature, Science Federal Institute, University of Zurich, CH-8093 Zurich, Switzerland

Pancreatic cancer is a uniformly lethal disease that is difficult to diagnose at early stage and even more difficult to cure. In recent years, there has been a substantial interest in applying proteomics technologies to identify protein biomarkers for early detection of cancer. Quantitative proteomic profiling of body fluids, tissues, or other biological samples to identify differentially expressed proteins represents a very promising approach for improving the outcome of this disease. Proteins associated with pancreatic cancer identified through proteomic profiling technologies could be useful as biomarkers for the early diagnosis, therapeutic targets, and disease response markers. In this article, we discuss recent progress and challenges for applying quantitative proteomics technologies for biomarker discovery in pancreatic cancer.

To whom correspondence should be addressed: Department of Medicine, Division of Gastroenterology, University of Washington, Seattle, WA 98195. Tel.: 206-543-3280; Fax: 206-685-9478; E-mail: teribr{at}u.washington.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Cell. ProteomicsHome page
X. Yi, J. M. Luk, N. P. Lee, J. Peng, X. Leng, X.-Y. Guan, G. K. Lau, L. Beretta, and S.-T. Fan
Association of Mortalin (HSPA9) with Liver Cancer Metastasis and Prediction for Early Tumor Recurrence
Mol. Cell. Proteomics, February 1, 2008; 7(2): 315 - 325.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Z. T. Hammoud, L. Dobrolecki, K. A. Kesler, E. Rahmani, K. Rieger, L. H. Malkas, and R. J. Hickey
Diagnosis of Esophageal Adenocarcinoma by Serum Proteomic Pattern
Ann. Thorac. Surg., August 1, 2007; 84(2): 384 - 392.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
R. Chen, T. A. Brentnall, S. Pan, K. Cooke, K. W. Moyes, Z. Lane, D. A. Crispin, D. R. Goodlett, R. Aebersold, and M. P. Bronner
Quantitative Proteomics Analysis Reveals That Proteins Differentially Expressed in Chronic Pancreatitis Are Also Frequently Involved in Pancreatic Cancer
Mol. Cell. Proteomics, August 1, 2007; 6(8): 1331 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. Ortiz-Zapater, S. Peiro, O. Roda, J. M. Corominas, S. Aguilar, C. Ampurdanes, F. X. Real, and P. Navarro
Tissue Plasminogen Activator Induces Pancreatic Cancer Cell Proliferation by a Non-Catalytic Mechanism That Requires Extracellular Signal-Regulated Kinase 1/2 Activation through Epidermal Growth Factor Receptor and Annexin A2
Am. J. Pathol., May 1, 2007; 170(5): 1573 - 1584.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
O. H. Ryu, J. C. Atkinson, G. T. Hoehn, G. G. Illei, and T. C. Hart
Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis
Rheumatology, September 1, 2006; 45(9): 1077 - 1086.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.